Streetbeat News

Equity Actions

OGI

OrganiGram Holdings Inc (NASDAQ:OGI) shares dropped 19% to $2.17 after announcing an overnight marketed public offering of 7.74 million units at C$3.23 each, totaling C$25 million. The offering includes an option for underwriters to purchase an additional 1.161 million units and is expected to close around April 2. The proceeds are intended for growth initiatives and general corporate purposes.

Portfolio Pulse from Henry Khederian

March 27, 2024 | 4:47 pm

SNX

TD SYNNEX Corporation (NYSE:SNX) reported Q1 earnings surpassing expectations with an EPS of $2.99 against a forecast of $2.84, despite missing revenue estimates. The company announced a $2 billion share repurchase program and a quarterly dividend of $0.40 per share. For Q2, TD SYNNEX anticipates revenues between $13.3 billion and $14.9 billion, with an adjusted EPS of $2.50-$3.00. Following the earnings report, Barclays and RBC Capital raised their price targets for SNX to $118.

Portfolio Pulse from Avi Kapoor

March 27, 2024 | 4:43 pm

CDLX

Cardlytics shares are trading higher following the announcement of a $150 million convertible senior notes offering.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 4:34 pm

BLUE

Analysts have diverse views on bluebird bio (NASDAQ:BLUE), with recent ratings ranging from indifferent to somewhat bearish. The average 12-month price target is now $2.92, down from $3.10. Analysts from RBC Capital, Wells Fargo, Wedbush, and HSBC have adjusted their price targets and ratings, reflecting changes in market conditions and company performance. bluebird bio's financials show significant revenue growth but challenges in net margin, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 4:01 pm

BXP

Boston Props (NYSE:BXP) has been analyzed by 7 analysts, showing a shift towards a more indifferent stance over the last three months, with 6 indifferent ratings currently. The average 12-month price target for BXP has increased to $71.86, up from $68.17, indicating a positive outlook. Analyst actions include both raises and lowers in ratings and price targets, reflecting a nuanced view of the company's prospects. Boston Props, owning over 190 properties, has shown solid financial performance with a revenue growth rate of 4.95%, a net margin of 14.47%, and a ROE of 2.06%, despite a high debt-to-equity ratio of 2.83.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 4:00 pm

DJT

META

NVDA

Trump Media & Technology Group (TMTG) debuted on NASDAQ with a valuation of $9.6 billion, 2000x its annual revenue, after a SPAC merger. The stock, previously under ticker DWAC, surged to $79.38, marking a 52-week high. Comparatively, NVIDIA trades at 38x estimated sales. TMTG's high valuation and potential as a meme stock could lead to volatility, especially with high short interest and the upcoming 2024 election cycle. Short sellers have already faced significant losses.

Portfolio Pulse from Chris Katje

March 27, 2024 | 3:59 pm

STOK

Stoke Therapeutics announced a proposed public offering of up to $75 million of common stock, leading to an increase in its share price.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 3:49 pm

FDV

KMB

SDG

Kimberly-Clark Corporation (NYSE:KMB) announced a transformation strategy aiming for growth through a new operating model, focusing on 12 brands, and investing in technology. The plan includes reorganizing into three segments, expecting to generate over $3 billion in productivity and $500 million in working capital savings. The transition, to be completed by end of 2024, will incur around $1.5 billion in restructuring costs. The company anticipates organic net sales and adjusted operating profit growth in the mid-to-high single digits, with an adjusted EPS growth in the same range, and at least $2 billion in annual FCF generation. The FY24 outlook remains unchanged, expecting a low-to-mid single digit increase in organic net sales.

Portfolio Pulse from Lekha Gupta

March 27, 2024 | 3:47 pm

DE

Investors have shown a mixed sentiment towards Deere (NYSE:DE), with options trading indicating both bullish and bearish positions. Benzinga's options scanner revealed 24 unusual trades, with a split sentiment of 45% bullish and 54% bearish. The trades focus on a price range between $310.0 and $480.0 for Deere. The largest trades include both calls and puts, with significant amounts invested. Deere, a leading agricultural equipment manufacturer, has seen its stock price increase by 0.47% to $398.9, though it may be overbought according to current RSI values. An analyst from Truist Securities has set a price target of $494.0 for Deere.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 3:31 pm

OGI

Organigram shares are trading lower following the announcement of pricing for an overnight marketed public offering.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 3:11 pm